David Pride
Infectious Disease · San Diego, CANPI 1194875526
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (59.9%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. 11 manufacturers reported payments, led by Roche Diagnostics Corporation at 44.7% of the total. Reporting peaked in 2022 at $17,428 and has fallen 79.0% since, to $3,661 in 2025. Among infectious disease clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 65 payments — averaging $921.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Roche Diagnostics Corporation$27K
- Gen-probe, Inc.$14K
- Cepheid$6K
- Biofire Diagnostics, LLC$5K
- Quidel Corporation$3K
- Hologic Sales And Service, LLC$2K
- plus $2K from 5 others
Across 116 payments — averaging $23,989 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Genmark Diagnostics, Inc.$1.3M
- Gen-probe, Inc.$742K
- Cepheid$405K
- Biomerieux Inc$242K
- Roche Diagnostics Corporation$77K
- Roche Molecular Systems, Inc.$55K
What the payments were for
- Consulting fees$17,48529%
- Speaking & faculty fees$35,87460%
- Travel & lodging$3,2665%
- Food & beverage$1,5223%
- Education$1,7703%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Roche Diagnostics Corporation | 16 | $26,797 |
| Gen-probe, Inc. | 12 | $14,479 |
| Cepheid | 10 | $6,300 |
| Biofire Diagnostics, LLC | 9 | $4,733 |
| Quidel Corporation | 1 | $3,000 |
| Hologic Sales And Service, LLC | 10 | $2,275 |
| Roche Molecular Systems, Inc. | 3 | $2,200 |
| Hologic Inc | 1 | $41 |
| Genmark Diagnostics, Inc. | 1 | $40 |
| Beckman Coulter, Inc. | 1 | $29 |
| Accelerate Diagnostics Inc. | 1 | $23 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- GENEXPERT$6,267
- Film Array System$4,525
- cobas 8000 Core Unit$4,280
- cobas#x00AE EBV$3,350
- Amplivue Lyra Solana Serosep$3,000
- cobas 4800 CTNG Test v20$2,900
- Aptima$2,120
- NONE$400
- cobas HBV/HCV/HIV-1 Control Kit$224
- cobas 6800 System$177
- PANTHER FUSION$135
- MD Microbiology$120
How this compares
$59,917 in reported general payments places this provider in the 95th percentile of 856 infectious disease providers in California.
Other infectious disease in San Diego
- George SakoulasSan Diego$902K
- Matthew WiklerSan Diego$161K
- Timothy WilkinSan Diego$63K
- Robert SchooleySan Diego$57K
- Douglas RichmanSan Diego$31K
- Saima AslamSan Diego$24K
- Claire PomeroySacramento$2.6M
- Javeed SiddiquiRoseville$1.5M
- Arthur JengSylmar$766K
- James McKinnellTorrance$762K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.